Pacira BioSciences, Inc. PCRX Business Segments — Other
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherCostOfOperatingRevenue.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s business segments — other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s business segments — other?
- Pacira BioSciences, Inc. (PCRX) reported business segments — other of $880K in Q1 2026.
- How has Pacira BioSciences, Inc.'s business segments — other changed year-over-year?
- Pacira BioSciences, Inc.'s business segments — other decreased by 52.7% year-over-year, from $1.86M to $880K.
- What is the long-term trend for Pacira BioSciences, Inc.'s business segments — other?
- Over 3 years (2022 to 2025), Pacira BioSciences, Inc.'s business segments — other has grown at a -9.4% compound annual growth rate (CAGR), from $22.17M to $16.51M.
- What does business segments — other mean?
- Represents miscellaneous operating expenses or income items within the reportable segment that do not fit into standard cost categories. Monitoring this helps identify non-core operational fluctuations that may impact the segment's overall financial performance.